Literature DB >> 16267771

The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis.

Afif Ben Salah1, Hechmi Louzir, Sadok Chlif, Mourad Mokni, Amor Zaatour, Mohamed Raouene, Riadh Ben Ismail, Koussay Dellagi.   

Abstract

To accurately quantify the different outcomes of Leishmania major infection and to evaluate the fraction of zoonotic cutaneous leishmaniasis (ZCL) cases prevented by naturally acquired leishmanin skin test (LST) reactivity, a cohort of 470 children was followed up in 2 endemic foci, Remada and Dhiba, in southern Tunisia. During May 1997, before the ZCL emergence season, LST was performed, and results were reassessed 12 months later. Active case detection during the ZCL emergence season showed a high incidence of ZCL: 57.0% in Remada and 13.7% in Dhiba. The preventive fraction of ZCL conferred by LST reactivity increased proportionally with the reaction size before the emergence season, revealing a dose-response effect of approximately 70%. In addition, asymptomatic L. major infection appeared to be a significant form of natural immunization, particularly in the context of relatively low transmission. These findings may help in the design and evaluation of vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267771     DOI: 10.1086/498042

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

2.  IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.

Authors:  R Novoa; O Bacellar; M Nascimento; T M Cardoso; R Ramasawmy; W N Oliveira; A Schriefer; E M Carvalho
Journal:  Parasite Immunol       Date:  2011-02       Impact factor: 2.280

3.  Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.

Authors:  Ifeoma Okwor; Dong Liu; Stephen M Beverley; Jude E Uzonna
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

4.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

5.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

6.  Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains.

Authors:  Fouad Benhnini; Mehdi Chenik; Dhafer Laouini; Hechmi Louzir; Pierre André Cazenave; Koussay Dellagi
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

7.  Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection.

Authors:  Angela Giudice; Célia Vendrame; Caroline Bezerra; Lucas P Carvalho; Thaís Delavechia; Edgar M Carvalho; Olívia Bacellar
Journal:  BMC Infect Dis       Date:  2012-03-29       Impact factor: 3.090

Review 8.  Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Authors:  Sreenivas Gannavaram; Ranadhir Dey; Kumar Avishek; Angamuthu Selvapandiyan; Poonam Salotra; Hira L Nakhasi
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

9.  Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia.

Authors:  Jihene Bettaieb; Amine Toumi; Sadok Chlif; Bilel Chelghaf; Aicha Boukthir; Adel Gharbi; Afif Ben Salah
Journal:  Parasit Vectors       Date:  2014-08-20       Impact factor: 3.876

10.  Age-related alteration of arginase activity impacts on severity of leishmaniasis.

Authors:  Ingrid Müller; Asrat Hailu; Beak-San Choi; Tamrat Abebe; Jose M Fuentes; Markus Munder; Manuel Modolell; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.